Differentiated Thyroid Cancer Patients More Than 60 Years Old Paradoxically Show an Increased Life Expectancy
- 22 January 2015
- journal article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 56 (2) , 190-195
Abstract
The aim of this study was to compare the overall survival of a large, single-center cohort of patients who had differentiated thyroid cancer (DTC) with that of a matched general population. We analyzed 2,428 consecutive patients who had DTC and underwent treatment from 1965 to 2013 at the Department of Nuclear Medicine, University Hospital of Münster, Münster, Germany, according to international standards. Patients were classified on the basis of the current, seventh edition of the American Joint Committee on Cancer/Union for International Cancer Control classification system. Additionally, a subgroup analysis with regard to age at diagnosis was performed. The overall survival of the patients was compared with the expected survival of the general population on the basis of age and sex, as provided by the Federal Statistical Office of Germany. Compared with the expected survival, the overall survival of patients with stage I disease paradoxically was significantly better (P < 0.001). In the subgroup analysis, a significantly lower mortality rate was observed in elderly patients (≥60 y old) with stage I disease. On the other hand, patients between 20 and 45 y of age and with distant metastases at diagnosis had a significantly increased standardized mortality rate. In contrast, other patients with stage II disease and more than 45 y old had a normal mortality rate. The mortality rate was significantly increased in all patients with stage IVC disease. Older patients with more limited disease paradoxically had better survival than would be expected on the basis of age and sex, whereas young adults as well as patients more than 45 y old and with distant metastases had increased mortality rates. For all other DTC patients, regardless of age or TNM stage, no significant survival difference was seen.Keywords
This publication has 29 references indexed in Scilit:
- Radioiodine for remnant ablation and therapy of metastatic diseaseNature Reviews Endocrinology, 2011
- TNM seventh edition: What's new, what's changedCancer, 2010
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- Poorly Differentiated Thyroid Carcinoma: The Turin Proposal for the Use of Uniform Diagnostic Criteria and an Algorithmic Diagnostic ApproachAmerican Journal of Surgical Pathology, 2007
- European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epitheliumEuropean Journal of Endocrinology, 2006
- Life expectancy in differentiated thyroid cancer: a novel approach to survival analysisEndocrine-Related Cancer, 2005
- Primary Malignancies of the Thyroid Epidemiologic Analysis of the Florida Cancer Data System RegistryAnnals of Epidemiology, 2000
- Papillary and Follicular Thyroid CarcinomaNew England Journal of Medicine, 1998
- Rank Tests and a One-Sample Logrank Test for Comparing Observed Survival Data to a Standard Population1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958